By Phil Englert
On January 30, 2025, the Cybersecurity and Infrastructure Security Agency (CISA) released medical advisory ICSMA-25-030-01, highlighting critical vulnerabilities in the Contec CMS8000 patient monitors. These vulnerabilities – which include an out-of-bounds write, hidden backdoor functionality, and privacy leakage – pose significant risks to patient safety and data security. The U.S. Food and Drug Administration (FDA) issued a safety communication on the same day, emphasizing the risks associated with these vulnerabilities. The FDA highlighted that the Contec CMS8000 and relabeled versions, such as the Epsimed MN-120, may be remotely controlled by unauthorized users, potentially compromising patient data and device functionality. The CMS8000 came on the market around 2005 and obtained FDA 510(k) clearance in June 2011.
The FDA’s recommendations for healthcare providers and patients were twofold: Unplug and discontinue the use of device if you rely on remote monitoring features. Second, the FDA recommended using local monitoring features only, such as disabling wireless capabilities and unplugging ethernet cables. Physiological monitors do not provide lifesaving or life-sustaining treatment, but they are essential in monitoring the condition of at-risk patients. Patient monitors are monitored centrally to promptly notify caregivers of patient condition changes. Rapid response can be the difference between good and bad outcomes.
The Contec CMS8000 patient monitor is widely used in healthcare settings to track vital signs such as heart rate, oxygen saturation, and blood pressure. I have two concerns. The first is patient safety. These monitors are designed to operate in a high acuity setting such as an ICU or CCU and to serve adult, pediatric, and neonatal patients. Most deployments would be connected to a patient monitoring network and central monitoring. Disconnecting these monitors from the network would reduce the effectiveness of patient monitoring in those settings where the patients are least resilient.
The vulnerabilities identified by CISA are particularly concerning because of the potential impact on patient care and data integrity.
- Out-of-Bounds Write (CVE-2024-12248): This vulnerability allows an attacker to send specially formatted UDP requests to write arbitrary data, potentially leading to remote code execution.
- Hidden Backdoor Functionality (CVE-2025-0626): The firmware contains a hard-coded IP address that bypasses existing network settings, enabling remote control and file manipulation.
- Privacy Leakage (CVE-2025-0683): Patient information and sensor data can be leaked to an unknown external network.
Claroty’s Team82 conducted an in-depth analysis of the Contec CMS8000 firmware and concluded that the issue is more likely an insecure design flaw rather than a hidden backdoor. The hard-coded IP address in the device’s firmware is listed in the operator manual, suggesting it is intended for internal network configuration rather than malicious purposes. Despite this, the insecure design poses significant risks, as it can be exploited to collect patient data or perform insecure firmware updates. Claroty’s research underscores the importance of addressing these vulnerabilities promptly to mitigate potential security threats.
Cylera’s threat intelligence research team also investigated the vulnerabilities and confirmed the presence of the hard-coded IP address linked to a Chinese university. Their analysis also supports the notion that the behavior observed in the Contec CMS8000 is not an intentional backdoor but a result of poor design choices. Cylera’s research highlights the potential consequences of these vulnerabilities, including the risk of compromised patient monitors being used as entry points for broader network attacks. The team recommends immediate remediation to prevent unauthorized access and data leakage.
The Claroty and Cylera research teams also noted that the IP address 202.114.4[.]119 is registered to the China Education and Research Network Center, Tsinghua University, Beijing, 100084, CN. This same IP address appears in several other manufacturer manuals: the Drager Vista CMS installation manual, the Mindray Patient Data Share Solution Guide, the Mindray VS-800 Vital Signs Monitor Operator’s Manual, the Edan M3A Vital Signs Monitor, and the Epsimed MN-120, a white-labeled CMS8000 monitor. Several manufacturers using the same IP address solution for managing monitor connectivity to the Central Monitor System is curious for sure. Was the design outsourced to a common provider? Did staffing changes leak a solution across companies? Was intellectual property stolen? We may never know. Inquiries to Contec have been unsuccessful.
Healthcare providers should review their central monitor configurations to determine proper and secure integration. Additionally, blocking outbound network traffic to unknown or malicious IP addresses is another effective protection. The FDA is unaware of any cybersecurity incidents, injuries, or deaths related to these cybersecurity vulnerabilities. The disclosure of these vulnerabilities has significant implications for healthcare providers. Ensuring the security of medical devices is crucial to maintaining patient safety and protecting sensitive health information. Healthcare facilities should consider proactive measures to address these vulnerabilities, including conducting thorough security assessments of medical devices, implementing network segmentation to isolate vulnerable devices, regularly updating firmware, and applying security patches.
The Contec CMS8000 vulnerabilities disclosed by CISA and analyzed by the FDA, Claroty, and Cylera highlight the critical need for robust cybersecurity measures in healthcare settings. It also highlights that vulnerabilities may stem from insecure design rather than malicious intent, their potential impact on patient safety and data security cannot be underestimated. Healthcare providers should act swiftly to mitigate these risks and ensure the integrity of their medical devices.
